Has Daniel Nguyen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,688 in general payments to Daniel Nguyen, MD across 72 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Nguyen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Nguyen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Nguyen, MD

Hospitalist · Baytown, TXNPI 1871666800

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,458 of the $3,688 with a category attached, or 66.7%. Boston Scientific accounts for 63.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $2,397 and has fallen 91.0% since, to $215 in 2025. Among hospitalist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,688in general payments, 2019–2025

Across 72 payments — averaging $51.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$2K
Nalu Medical, Inc.$280
Relievant Medsystems, Inc.$268
Sun Pharmaceutical Industries Inc.$137
Ortho Dermatologics, A Division Of Bausch Health US, LLC$123
Inari Medical, Inc.$113
plus $415 from 9 others

What the payments were for

Travel & lodging$1,23033%
Food & beverage$2,45867%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	27	$2,351
Nalu Medical, Inc.	15	$280
Relievant Medsystems, Inc.	5	$268
Sun Pharmaceutical Industries Inc.	1	$137
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$123
Inari Medical, Inc.	1	$113
Cook Medical LLC	2	$108
Collegium Pharmaceutical, Inc.	6	$85
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$73
Johnson & Johnson	3	$43
Kowa Pharmaceuticals America, Inc.	2	$34
UCB, Inc.	1	$23
Amgen	1	$18
Fidia Pharma USA Inc.	1	$17
Idorsia Pharmaceuticals US Inc	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,688 in reported general payments places this provider in the 95th percentile of 1,284 hospitalist providers in Texas.

See all hospitalist providers in Texas →

Medicare billing

Part B allowed, 2024

$67,885

Medicare patients

217

Services billed

583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	13	$8,099
Methenamine Hippurate	13	$1,267
Gabapentin	30	$301
Pantoprazole Sodium	19	$174
Doxycycline Hyclate	11	$132
Furosemide	36	$131
Cephalexin	12	$127
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$122
Potassium Chloride	13	$118
Losartan Potassium	15	$112
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	12	$112
Atorvastatin Calcium	16	$89
Carvedilol	14	$66
ClopidogrelClopidogrel Bisulfate	12	$64
Metoprolol Tartrate	26	$59

Paid to pharmacies, not to this prescriber.

Other hospitalist in Baytown

Rody Bou ChaayaBaytown$6K
Maricel JumawanBaytown$3K
Kenechukwu EnekebeCorpus Christi$311K
Ryan NealHouston$154K
Sarah SmileyAustin$90K
Mubeen CheemaSan Antonio$50K
Ahmad BaroutHouston$44K
Tarek HammadSan Antonio$42K
Hendre FichardtSan Antonio$36K
Sadie Trammell VelasquezSan Antonio$36K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →